WebOct 22, 2024 · Cisplatin, powder or solution per 10 mg IV J9060 Cladribine per mg IV J9065 Claforan, see Cefotaxime sodium Clofarabine 1 mg IV J9027 . 2024 Table of Drugs 2024 Table of Drugs ... WebNDC HCPCS Product NDC: 68001-0283 Brand Name: Cisplatin Generic Name: Cisplatin Dosage Form Name: Injection Administration Route: Intravenous Substances: Name: Cisplatin Strength: 1.0 Unit: mg/mL Packages: Code: 68001-0283-27 Description: 1 VIAL in 1 CARTON (68001-283-27) / 50 mL in 1 VIAL (68001-283-24) Effective Date: Aug. 2, …
Etoposide Capsule: Package Insert - Drugs.com
WebRecommended Dose: 500 mg/m^2 as an intravenous infusion over 10 minutes on Day 1 of each 21-day cycle, administered as a single agent or with cisplatin, in patients with creatinine clearance of 45 mL/minute or greater. See full prescribing information for further detail. For Medicaid and NC Health Choice Billing WebJun 1, 2024 · Non-Small Cell Lung Cancer Gemcitabine for injection in combination with cisplatin is indicated for the first-line treatment of patients with inoperable, locally advanced (Stage IIIA or IIIB) or metastatic (Stage IV) non-small … trylets-keto.com
44567-0530 Cisplatin - CanMED: NDC - SEER
WebApr 3, 2024 · §Overall = 0 to 120 hours post-initiation of cisplatin chemotherapy. ... NDC 31722-165-31 1 vial per carton. Storage Fosaprepitant for injection vials must be refrigerated, store at 2°C to 8°C (36°F to 46°F). The reconstituted final drug solution is stable for 24 hours at ambient room temperature [at or below 25°C (77°F)]. ... WebCisplatin is an antineoplastic agent that is FDA approved for the treatment of metastatic testicular tumors, metastatic ovarian tumors, and advanced bladder cancer. There is a Black Box Warning for this drug as shown here. Common adverse reactions include anemia, leukopenia, and thrombocytopenia . Adult Indications and Dosage WebNov 1, 2024 · Emend ® capsules, in combination with other antiemetic agents, is indicated in patients 12 years of age and older for the prevention of: acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy (HEC) including high-dose cisplatin. trylfer